Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases

Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases

AIM: To assess the risk of severe adverse events (AEs) within 6 months after treatment with biological agents in patients with rheumatic diseases (RD)/MATERIAL AND METHODS: The 6-month open-label trial included 107 patients with rheumatoid arthritis, antineutrophil cytoplasmic antibody-associated va...

Full description

Bibliographic Details
Main Authors:	S V Moiseev, P I Novikov, E N Semenkova, L A Strizhakov, S V Guliaev, T N Ianushkevich, N V Nikiforova, A D Meshkov, V V Panasiuk, Iu D Sorokin, M V Taranova, S A Parfenova, L V Dubrovskaia, E S Zhabina, E I Kuznetsova, I A Lopatina, N M Bulanov, N A Mukhin
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2013-05-01
Series:	Терапевтический архив
Subjects:	genetically engineered biological agents rheumatic diseases vasculitis rheumatoid arthritis systemic lupus erythematosus safety efficiency
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31268

Similar Items

Evaluation of the short-term efficacy and safety of biological agents in different rheumatic diseases: a multidisciplinary therapeutic hospital"s experience
by: N A Mukhin, et al.
Published: (2013-04-01)

Giant cell arteritis: Genetic and epigenetic aspects
by: S V Guliaev, et al.
Published: (2017-08-01)

Поражение сердца при системных васкулитах: патогенетические звенья, значение факторов риска развития сердечно-сосудистых осложнений и диагностика
by: L A Strizhakov, et al.
Published: (2014-12-01)

CARDIOVASCULAR COMPLICATIONS AND ENDOTHELIAL DYSFUNCTION IN PRIMARY VASCULITIS
by: L A Strizhakov, et al.
Published: (2012-05-01)

Giant cell arteritis as a cause of fever of unclear genesis in the elderly
by: S V Guliaev, et al.
Published: (2014-12-01)

From Schönlein-Henoch purpura to IgA-vasculitis: pathogenetic aspects of the disease
by: S V Guliaev, et al.
Published: (2018-10-01)

Pulmonary hypertension in rheumatic heart disease: current approaches to diagnosis and therapy
by: N A Shostak, et al.
Published: (2012-09-01)

Severe Wegener's granulomatosis successfully treated with rituximab
by: E N Semenkova, et al.
Published: (2010-06-01)

Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease
by: V. I. Ignatyeva, et al.
Published: (2019-01-01)

Role of the intestinal MALT in pathogenesis of the IgA-nephropathy
by: Sergei V. Guliaev, et al.
Published: (2021-06-01)

Osteoarthrosis in the clinic of internal and occupational diseases: differential diagnostic aspects
by: Leonid A. Strizhakov, et al.
Published: (2020-07-01)

Neurohumoral regulation of blood pressure in rheumatic patients
by: N P Shilkina, et al.
Published: (2009-06-01)

Psychopharmacotherapy for depression in rheumatic patients
by: N V Yaltzeva, et al.
Published: (2016-05-01)

Clinical features of kidney involvement in microscopic microscopic polyangiitis
by: E M Shchegoleva, et al.
Published: (2018-06-01)

Systemic lupus erythematosus with the development of neuromyelitis optica (Devic's syndrome) is a rare combination of autoimmune diseases
by: E. S. Vinogradova, et al.
Published: (2019-10-01)

Morphological verification of renal lesion as a compulsory stage in the diagnosis of Fabry disease
by: P V Glybochko, et al.
Published: (2014-12-01)

Bosentan: A considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases
by: A V Volkov, et al.
Published: (2014-05-01)

Diagnosis of acute rheumatic fever
by: B. S. Belov, et al.
Published: (2016-10-01)

Differential diagnosis of rheumatic diseases and blood cancers involving the nasal cavity and accessory sinuses
by: V I Vasil'ev, et al.
Published: (2014-05-01)

Rheumatic manifestations of hypothyroidism
by: L. V. Teplova, et al.
Published: (2017-04-01)

SUBCLINICAL CARDIOVASCULAR SYSTEM INVOLVEMENT IN RHEUMATIC DISEASES
by: A. L. Maslyansky, et al.
Published: (2015-05-01)

Digestive comorbidity in patients with rheumatic diseases: Not only NSAID-induced gastropathy
by: A. E. Karateev, et al.
Published: (2016-10-01)

Risk factors of atherosclerosis and clinical and morphological comparisons in systemic vasculitides
by: Leonid Aleksandrovich Strizhakov, et al.
Published: (2012-08-01)

Bone status in young women with rheumatic diseases
by: O. V. Dobrovolskaya, et al.
Published: (2019-12-01)

Cardiorenal syndrome in ischemic renal disease (atherosclerotic renovascular hypertension)
by: N A Mukhin, et al.
Published: (2008-08-01)

The place of aceclofenac in the preparation of patients with rheumatic diseases for joint surgery
by: V. N. Amirdzhanova, et al.
Published: (2019-10-01)

RHEUMATIC FEVER AS NONVANISHING DISEASE: A PROBLEM STATE AND CLINICAL CASES
by: N. A. Shostak, et al.
Published: (2016-01-01)

Chlamydial infection in rheumatic diseases
by: S V Shubin, et al.
Published: (2008-02-01)

Imitators of severe preeclampsia: on differential diagnosis and multidisciplinary management
by: A. N. Strizhakov, et al.
Published: (2019-05-01)

KONSUPREN IN THETHERAPY OF RHEUMATIC DISEASES
by: Z S Alekberova, et al.
Published: (2001-04-01)

EXTRACELLULAR DNA AND THE LEVEL OF ITS METHYLATION IN DIFFERENT RHEUMATIC DISEASES
by: N O Shubayeva, et al.
Published: (2012-02-01)

Gastro-intestinal complications as one of causes of death in patients with rheumatic diseases
by: V N Sorotskaya, et al.
Published: (2005-08-01)

Neurohumoral relationship in patients with rheumatic diseases
by: I. V. Dryazenkova, et al.
Published: (2004-02-01)

Cornea verticillata in Fabry disease
by: S V Moiseev, et al.
Published: (2018-12-01)

Invasive aspergillosis in adult patients with rheumatic diseases
by: V. I. Mazurov, et al.
Published: (2020-11-01)

Bone mineral density and fracture risk in patients with rheumatic diseases
by: O. V. Dobrovolskaya, et al.
Published: (2020-07-01)

Efficacy of genetically engineered biological agents in the treatment of uveitis associated with rheumatic diseases in children
by: V V Neroyev, et al.
Published: (2012-08-01)

NON-RHEUMATIC MYOCARDITIDES
by: N. A. Shostak, et al.
Published: (2015-10-01)

Experience with Karmolis liquid administration for rheumatic diseases local therapy (data of multicenter clinical examination)
by: L N Denisov, et al.
Published: (2005-10-01)

Cardiorenai interactions: ciinicai indications and roie in pathogenesis of cardiovascular and renal diseases
by: N A Mukhin, et al.
Published: (2004-06-01)